# Evaluation of Risk of hEpatocellular Carcinoma

> **NCT06523179** · NA · RECRUITING · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 500 (estimated)

## Conditions studied

- NASH
- HCC
- Genetic Predisposition

## Interventions

- **OTHER:** quantify the impact of genetic risk factors

## Key facts

- **NCT ID:** NCT06523179
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-01-01
- **Primary completion:** 2030-01-01
- **Final completion:** 2035-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06523179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06523179, "Evaluation of Risk of hEpatocellular Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06523179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*